Skip to main content

Table 1 Basic characteristics and outcomes illustrating liver dysfunction, severity of illness and outcome

From: Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction

Parameters

Results

Age, years

59.1 ± 12.4

Male sex, n (%)

47 (68.1)

BMI, kg/m2

26.5 ± 4.6

Pre-existing liver disease (double appointment is possible)

 Cirrhosis, n (%)

42 (60.9)

 Hepatitis B or C, n (%)

10 (14.5)

 Alcoholic cirrhosis, n (%)

20 (29)

 Hepatocellular carcinoma, n (%)

9 (13)

 Others, n (%)

22 (31.9)

 MELD score at admission

19.7 ± 9.6

Severity of illness

 Maximum SAPS II score during stay at hospital

56.2 ± 13.6

 Maximum TISS score during stay at hospital

24.2 ± 8.9

 Sepsis during dialysis period, n (%)

29 (42)

 Mechanical ventilation during stay in ICU, n (%)

57 (82.6)

Outcome

 Duration of ventilation, h

425.5 ± 507.8

 Length of stay in hospital, days

62.9 ± 64.9

 Length of stay in ICU, days

30.4 ± 31.8

 Death, n (%)

40 (58.0)

  1. Abbreviations: BMI Body mass index, ICU Intensive care unit, MELD Model for End-stage Liver Disease, SAPS II Simplified Acute Physiology Score II, TISS Therapeutic Intervention Scoring System
  2. Results are shown as mean ± SD or as the number of patients and corresponding percentage with respect to all 69 patients